5-Dibromomethyl anastrozole is a synthetic derivative of anastrozole characterized by a dibromomethyl substitution at the 5-position of the triazole ring. This structural modification introduces two bromine atoms on the methyl group, altering the electronic and steric properties relative to the parent compound. The triazole core retains its conjugation with the adjacent phenyl ring, preserving key pharmacophoric interactions. This impurity arises via bromination of the methyl substituent during synthetic pathways or degradation processes. It serves as a critical HPLC reference standard for quantifying process-related impurities in anastrozole drug substance.
On Request